A second draft of Annex 1, the EU’s GMP guideline, is now in the works and seeking input from targeted stakeholders. This webinar covers what is in the current Annex 1; what’s changed between revisions; and how any changes might affect the pharmaceutical industry, with focus on comments regarding the fundamental principles and guidance of Contamination Control Strategy (CCS) for sterile and non-sterile medicinal products.
Additonally, view our webinar series on Annex 1 focusing on environmental monitoring and cleanroom qualifications, as well as quality control and bioburden testing.
Lucia Ceresa, PhD
Senior Technology and Market Development Manager
During this time of uncertainty, we are focused on providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.